#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14658	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2195	664.0	0	.	n	.	0	C451T	SNP	451	451	C	793	793	T	783	T,C	413,332	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14658	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2195	664.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1526	1526	C	801	C	757	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14658	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2195	664.0	0	HET	.	.	.	C207T	.	207	207	C	549	549	C	835	C,T	613,162	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26554	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3536	747.9	0	.	n	.	0	T695C	SNP	695	695	T	1040	1040	C	836	C,T,A	783,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26554	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3536	747.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2316	2316	C	885	C,A,T	821,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26554	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3536	747.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2390	2390	A	831	A	789	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26554	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3536	747.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2942	2942	C	861	C,A,T	811,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26554	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3536	747.9	0	HET	.	.	.	A1638G	.	1638	1638	A	1983	1983	A	808	A,G	418,357	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1890	folP	855	855	100.0	folP.l15.c30.ctg.1	1648	114.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1041	1043	AGC	206;204;202	A,G;G;C	189,1;190;189	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5048	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3415	147.5	1	SNP	p	S91F	1	.	.	271	273	TTC	655	657	TTC	172;171;171	T;T;C	161;159;160	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5048	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3415	147.5	1	SNP	p	D95G	1	.	.	283	285	GGC	667	669	GGC	167;165;163	G;G;C	156;155;155	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5048	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3415	147.5	1	SNP	p	G95N	0	.	.	283	285	GGC	667	669	GGC	167;165;163	G;G;C	156;155;155	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1596	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1318	120.1	1	SNP	p	G45D	0	.	.	133	135	GGC	499	501	GGC	213;213;215	G;G;C	202;203;205	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	818	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1020	79.5	0	.	n	.	0	A197.	DEL	197	197	A	539	539	A	185	A	178	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5626	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2846	196.2	1	SNP	p	D86N	0	.	.	256	258	GAC	582	584	GAC	201;197;202	G;A;C	189;184;192	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5626	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2846	196.2	1	SNP	p	R87W	0	.	.	259	261	CGT	585	587	CGT	206;205;206	C;G;T	196;192;194	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5626	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2846	196.2	1	SNP	p	R87I	0	.	.	259	261	CGT	585	587	CGT	206;205;206	C;G;T	196;192;194	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5626	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2846	196.2	1	SNP	p	S87R	1	.	.	259	261	CGT	585	587	CGT	206;205;206	C;G;T	196;192;194	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5626	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2846	196.2	1	SNP	p	S88P	0	.	.	262	264	TCC	588	590	TCC	205;206;206	T;C;C	194;196;195	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3974	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2557	154.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1557	1559	GGC	177;177;170	G;G;C	166;166;159	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3834	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2434	156.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1263	1265	GCC	217;219;219	G;C;C,A	204;205;204,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3834	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2434	156.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1266	1268	ATG	218;217;219	A;T;G,C	204;202;203,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3834	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2434	156.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1278	1280	ACC	204;205;209	A,G;C,T;C,G	189,1;191,1;194,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3834	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2434	156.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1278	1280	ACC	204;205;209	A,G;C,T;C,G	189,1;191,1;194,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3834	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2434	156.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1779	1781	ACC	229;230;234	A;C;C	211;215;218	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3834	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2434	156.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1833	1835	GCG	213;212;209	G;C;G	203;203;196	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3834	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2434	156.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1833	1835	GCG	213;212;209	G;C;G	203;203;196	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3834	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2434	156.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1956	1958	GGT	146;145;140	G;G;T	137;136;134	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3834	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2434	156.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1965	1967	AGC	133;131;130	A;G;C	128;126;123	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3834	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2434	156.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1983	1985	CCG	122;123;124	C,G;C,G;G	99,4;102,1;102	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5826	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3154	184.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1663	1665	CCG	221;220;225	C,A;C;G	205,1;211;207	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2528	porA	1146	1146	99.91	porA.l6.c17.ctg.1	1825	137.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	598	598	C	162	C	151	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2926	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1626	178.7	1	SNP	p	G120K	1	.	.	358	360	AAG	678	680	AAG	238;239;243	A;A;G	225;230;232	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2926	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1626	178.7	1	SNP	p	N121D	0	.	.	361	363	AAC	681	683	AAC	242;243;246	A;A;C,T	230;232;232,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2926	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1626	178.7	1	SNP	p	A121N	1	.	.	361	363	AAC	681	683	AAC	242;243;246	A;A;C,T	230;232;232,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10584	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4882	216.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1094	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	971	111.7	1	SNP	p	V57M	1	.	.	169	171	ATG	511	513	ATG	231;232;231	A;T;G	218;220;218	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
